What actually moved these stocks

Ambarella, a fabless designer of low-power vision chips used in security cameras, robotics and automotive driver-assistance systems, closed at $86.00 on July 31, up roughly 24.6% over five sessions and 16.1% in a single day. The move was not an earnings beat or a design-win conversion — it followed a Financial Times report, relayed by SiliconAngle, that NXP Semiconductors is in preliminary talks to acquire Ambarella, discussions the report itself called unconfirmed and possibly going nowhere. Coverage of the same report noted NXP's automotive business already accounts for roughly half its $15.1B revenue, and NXP shares fell on the news while Ambarella's jumped. Ambarella's own Q1 FY2027 results, reported in late May, showed revenue growth decelerating to 16.9% year over year from 37% for the prior full fiscal year, with inventory days ballooning to 145 from 99 on a pre-build ahead of expected memory-chip price hikes — the opposite of what a demand inflection should look like.

CEVA, a fabless licensor of digital-signal-processor and AI inference IP that earns royalties across consumer, automotive and robotics chips rather than selling silicon directly, fell roughly 18-19% into July 29 before a partial recovery. That drop coincided with disclosure that chief operating officer Michael Boukaya agreed to step down from his operating role effective August 1, even as CEVA's own reporting showed royalty revenue flat year over year with smart-edge royalties up 8% and a new NeuPro-M AI licensing deal signed with a major platform partner in the same window — no sign of the unit-volume or royalty-rate deterioration that would justify the drop on fundamentals alone.

The wider chip market, and where the two names sit

Both declines landed atop a broader rout: chip stocks including SK Hynix, Samsung and SoftBank shed more than $1 trillion in market value the week of July 28-29 on AI-debt jitters and China chipmaking progress, a move Bloomberg framed as a deepening rotation away from AI-exposed tech. AMBA and CEVA actually tracked each other through most of the spring and summer — both sat in sustained uptrends simultaneously from late May through late July — so the split the hypothesis flags is confined to the final week and traces to two unrelated headlines, not a genuine cohort turn. Socket competition is real regardless: Qualcomm's 2026 Dragonwing IQ10 launch was explicitly positioned as a power-efficient alternative to NVIDIA Jetson for the same edge-vision workloads both companies depend on.

On valuation, Ambarella trades near 98x forward non-GAAP earnings and about 6.8x forward sales against roughly 13% consensus growth, with trailing price-to-sales at 7.72x — a multiple a July fundamentals memo pegged as fair value below $60, well under the current print. CEVA's trailing price-to-sales sits near 10.09x; its forward multiple could not be independently confirmed this cycle, so its valuation picture is directionally a possible dislocation — a falling price with no visible fundamental deterioration — rather than a fully quantified one.

The setup

Where it stands — AMBA rallied on unconfirmed M&A talk while revenue growth decelerated and inventory built; CEVA fell on a COO exit and sector selloff despite flat-to-rising royalties. Would confirm — A completed or formally confirmed NXP-Ambarella transaction, or Ambarella's next quarterly revenue reaccelerating above 20% YoY. Would invalidate — NXP or Ambarella confirming no deal is proceeding, or Ambarella's inventory days failing to normalize toward 100 next quarter. Watch next — Ambarella's Q2 FY2027 results, due roughly late August 2026, the first since the NXP report. Valuation — AMBA near 98x forward EPS and 6.8x forward sales versus a memo-cited fair value below $60; CEVA near 10x trailing sales, forward multiple unconfirmed.